Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD

CONCLUSIONS: Approximately one third of CHB + NAFLD patients were non-obese. Non-obese patients, while less metabolically abnormal, had a similar risk for fibrosis progression as obese patients. Obesity status did not impact the efficiency of antiviral therapy.PMID:38097430 | DOI:10.1016/j.jfma.2023.12.001

Source: J Formos Med Assoc - December 14, 2023 Category: General Medicine Authors: Danqing Hu Peng Wang Xiaojing Wang Xue Hu Da Huang Weiming Yan Dong Xi Meifang Han Qin Ning Hongwu Wang Source Type: research